We are live on ! Find out more
REVS icon

Columbia Research Enhanced Value ETF
REVS

2 hedge funds and large institutions have $3.85M invested in Columbia Research Enhanced Value ETF in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.96% less ownership

Funds ownership: 99.3% → 98.34% (-0.96%)

27% less capital invested

Capital invested by funds: $5.27M → $3.85M (-$1.42M)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$4.56M
2
Jane Street
Jane Street
New York
+$16.7K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$5.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
1
Ameriprise
Minnesota
$3.68M +$4.56M +234,550 New
Jane Street
2
Jane Street
New York
$177K +$16.7K +858 +8%
Wells Fargo
3
Wells Fargo
California
– -$5.05M -237,800 Closed

REVS Hedge Fund Activity: Q1 2020 in Review

2 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q1 2020, worth a combined $3.85M — down 27% from $5.27M a quarter earlier.

Fund positioning in REVS was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Ameriprise, opening a new position worth an estimated $4.56M. The largest seller was Wells Fargo, exiting entirely with an estimated $5.05M sold.

  • 2 institutional investors held Columbia Research Enhanced Value ETF (REVS) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $3.85M of Columbia Research Enhanced Value ETF stock for Q1 2020, down 27% quarter-over-quarter.
  • 1 fund opened new Columbia Research Enhanced Value ETF positions in Q1 2020 and 1 closed out, a net change of 0 holders.
  • The largest Columbia Research Enhanced Value ETF buyer in Q1 2020 was Ameriprise, an estimated $4.56M added.
  • The largest Columbia Research Enhanced Value ETF seller in Q1 2020 was Wells Fargo, an estimated $5.05M sold.

Based on aggregated 13F filings for Q1 2020.